AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

10 Nov
AHFS Drug Information logo
AHFS November 2020 Update

This update contains 1 new monograph and 10 revised monographs.

New monograph: Pralsetinib

Revised monographs: Raltegravir Potassium; Ofatumumab (Antineoplastic); Tagraxofusp-erzs; Polatuzumab Vedotin-piiq; Zanubrutinib; Avapritinib; Remdesivir; Ofatumumab (Multiple Sclerosis); Opiate Agonists General Statement; Antiretroviral Agents General Statement

13 Oct
AHFS Drug Information logo
AHFS October 2020 Update

This update contains 9 new monographs, 25 revised monographs and 1 new MedWatch alert.

New monographs: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf; Fostemsavir; Amisulpride; Tafasitamab-cxix; Belantamab Mafodotin-blmf; Viltolarsen; Risdiplam; Ofatumumab; Satralizumab-mwge

Revised monographs: Nitric Oxide; Propofol; Influenza Vaccine Live Intranasal; Remifentanil; Golimumab; Ustekinumab; Brentuximab; Influenza Vaccine Recombinant; Elbasvir and Grazoprevir; Bictegravir, Emtricitabine, and Tenofovir Alafenamide; Glasdegib; Alpelisib; Upadacitinib; Fedratinib; Entrectinib; Remdesivir; HYDROmorphone; Neostigmine; Warfarin; Probenecid; SUFentanil; Influenza Virus Vaccine Inactivated; Immunization Schedules; Anti-infectives Available from CDC; Immunobiologic Agents Available from CDC

New MedWatch alert on the following monograph: HYDROmorphone

08 Sep
AHFS Drug Information logo
AHFS September 2020 Update

This update contains 4 new monographs, 24 revised monographs and 18 new MedWatch alerts.

New monographs: Selpercatinib; Inebilizumab-Cdon; Lurbinectedin; Decitabine And Cedazuridine

Revised monographs: Remifentanil; Tapentadol; Dolutegravir and Rilpivirine; Dolutegravir and Lamivudine; Brolucizumab; HYDROcodone; Levorphanol; Codeine; Meperidine; OxyMORphone; OxyCODONE; Morphine; Methadone; Bacitracin; Opium; Pentazocine; FentaNYL; Butorphanol; Nalbuphine; Neomycin; Opiate Agonists General Statement; SUFentanil; Buprenorphine; TraMADol

New MedWatch alerts on the following monographs: Remifentanil; Tapentadol; HYDROcodone; Levorphanol; Codeine; Meperidine; oxyMORphone; OxyCODONE; Morphine; Methadone; Opium; Pentazocine; FentaNYL; Butorphanol; Nalbuphine; SUFentanil; Buprenorphine; TraMADol

 
11 Aug
AHFS Drug Information logo
AHFS August 2020 Update

This update contains 2 new monographs, 12 revised monographs and 1 discontinued monograph.

New monographs: Capmatinib; Ripretinib

Revised monographs: Brentuximab; Sofosbuvir; Ledipasvir and Sofosbuvir; Ixekizumab; Sofosbuvir and Velpatasvir; Bictegravir, Emtricitabine, and Tenofovir Alafenamide; Romosozumab-aqqg; Bremelanotide; Selinexor; Remdesivir; Chloroquine; Hydroxychloroquine

Discontinued monograph: Daclatasvir

14 Jul
AHFS Drug Information logo
AHFS July 2020 Update

This update contains 6 new monographs, 15 revised monographs and 1 new MedWatch alert.

New monographs: Pemigatinib; Sacituzumab Govitecan-Hziy; Remdesivir; Tucatinib; Lemborexant; Opicapone

Revised monographs: Mifepristone; Propofol; Tegaserod; Ivermectin; Sapropterin; Abiraterone; Alemtuzumab; Ocrelizumab; Elagolix; Siponimod; Darolutamide; Tenapanor; Neostigmine; Pyridostigmine; Digoxin Immune Fab

New MedWatch alert on the following monograph: Ivermectin

09 Jun
AHFS Drug Information logo
AHFS June 2020 Update

This update contains 4 new monographs, 25 revised monographs and 1 new MedWatch alert.

New monographs: Crotalidae Immune F(ab’)2 (Equine); Osilodrostat; Ozanimod; Selumetinib

Revised monographs: Nitric Oxide; Crotalidae Polyvalent Immune Fab; Epoprostenol; Asparaginase (Erwinia chrysanthemi; Crofelemer; Elbasvir and Grazoprevir; Palbociclib; Olaratumab; Ribociclib; Sofosbuvir, Velpatasvir, and Voxilaprevir; Glecaprevir and Pibrentasvir; Abemaciclib; Triclabendazole; Calaspargase Pegol-mknl; Erdafitinib; Chloroquine; Hydroxychloroquine; Carbamide Peroxide; Ascorbic Acid; RaNITIdine; Pentostatin; Pegaspargase; Antineoplastic Agents; Antitoxins, Immune Globulins, Toxoids, and Vaccines; Miscellaneous Therapeutic Agents

New MedWatch alert on the following monograph: RaNITIdine

View more View all content updates